Therefore, it could be envisaged that under the conditions that exist in patients harboring prostate cancer, a substantial amount of α2M* is available to bind to cell surface GRP78 thus triggering mitogenic signaling and promoting cellular proliferation. This evidence concerns the gene HSPA5 and prostate cancer.